These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 18726185)

  • 21. [Association of renal carcinoma with neuromyotonia and involvement of inferior motor neuron].
    Cánovas D; Martínez JM; Viguera M; Ribera G
    Neurologia; 2007; 22(6):399-400. PubMed ID: 17610170
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paraneoplastic syndrome of renal cell carcinoma.
    Minai FN; Monem A
    J Coll Physicians Surg Pak; 2006 Jan; 16(1):81-2. PubMed ID: 16442001
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Central retinal vein occlusion and renal cell carcinoma.
    Adrean SD; Schwab IR
    Am J Ophthalmol; 2003 Dec; 136(6):1185-6. PubMed ID: 14644245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stauffer's syndrome variant associated with renal cell carcinoma.
    Giannakos G; Papanicolaou X; Trafalis D; Michaelidis I; Margaritis G; Christofilakis C
    Int J Urol; 2005 Aug; 12(8):757-9. PubMed ID: 16174051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-Ri-associated paraneoplastic ophthalmoplegia-ataxia syndrome in a woman with breast cancer: a case report and review of the literature.
    Sena G; Gallo G; Vescio G; Gambardella D; de Franciscis S; Renne M
    J Med Case Rep; 2020 Jun; 14(1):67. PubMed ID: 32527295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myasthenia gravis associated with renal cell carcinoma: a paraneoplastic syndrome or just a coincidence.
    Zheng Y; Luo J; Jin H; Liu R; Hao H; Gao F
    BMC Neurol; 2021 Jul; 21(1):277. PubMed ID: 34253185
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A case of paraneoplastic cerebellar ataxia secondary to renal cell carcinoma.
    Ammar H; Brown SH; Malani A; Sheth HK; Sollars EG; Zhou SX; Gupta C; Mughal S
    South Med J; 2008 May; 101(5):556-7. PubMed ID: 18414160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Anticerebellar antibodies--anti-Hu and anti-Yo--in the diagnosis of paraneoplastic neurologic syndromes].
    Grisold W; Drlicek M; Liszka U
    Nervenarzt; 1991 Oct; 62(10):609-14. PubMed ID: 1749452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-Yo antibody-mediated paraneoplastic cerebellar degeneration in a female patient with pleural malignant mesothelioma.
    Tanriverdi O; Meydan N; Barutca S; Ozsan N; Gurel D; Veral A
    Jpn J Clin Oncol; 2013 May; 43(5):563-8. PubMed ID: 23475537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibodies to a subpopulation of glial cells and a 66 kDa developmental protein in patients with paraneoplastic neurological syndromes.
    Honnorat J; Antoine JC; Derrington E; Aguera M; Belin MF
    J Neurol Neurosurg Psychiatry; 1996 Sep; 61(3):270-8. PubMed ID: 8795598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal cell carcinoma and vasculitis: report of two cases.
    Hoag GN
    J Surg Oncol; 1987 May; 35(1):35-8. PubMed ID: 3573771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autoimmune pathogenesis of paraneoplastic neurological syndromes.
    Anderson NE; Cunningham JM; Posner JB
    Crit Rev Neurobiol; 1987; 3(3):245-99. PubMed ID: 3315239
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyperglycemia as a paraneoplastic endocrinopathy in renal cell carcinoma: a case report and review of the literature.
    Jobe BA; Bierman MH; Mezzacappa FJ
    Nebr Med J; 1993 Nov; 78(11):349-51. PubMed ID: 8309485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Guillain-Barre syndrome: a typical paraneoplastic syndrome in a kidney transplant recipient with allograft renal cell carcinoma: a case report and review of the literature.
    Zakrocka I; Baranowicz-Gąszczyk I; Korolczuk A; Załuska W
    BMC Nephrol; 2020 Oct; 21(1):434. PubMed ID: 33054714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with antineuronal autoantibodies.
    Uchuya M; Graus F; Vega F; Reñé R; Delattre JY
    J Neurol Neurosurg Psychiatry; 1996 Apr; 60(4):388-92. PubMed ID: 8774401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Necrotizing myopathy as a paraneoplastic syndrome associated with renal cell carcinoma.
    Naert E; De Bleecker JL; Lumen N; Rottey S
    Acta Clin Belg; 2015 Feb; 70(1):61-4. PubMed ID: 25268468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A large screen for paraneoplastic neurological autoantibodies; diagnosis and predictive values.
    Seluk L; Taliansky A; Yonath H; Gilburd B; Amital H; Shoenfeld Y; Kivity S
    Clin Immunol; 2019 Feb; 199():29-36. PubMed ID: 30543927
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diffuse retroperitoneal amyloidosis due to renal cell carcinoma.
    Coakley FV; Hricak H; Presti JC; Small EJ
    Br J Radiol; 1999 Apr; 72(856):412-3. PubMed ID: 10474508
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GAD antibody positive paraneoplastic stiff person syndrome in a patient with renal cell carcinoma.
    McHugh JC; Murray B; Renganathan R; Connolly S; Lynch T
    Mov Disord; 2007 Jul; 22(9):1343-6. PubMed ID: 17486640
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Paraneoplastic syndromes associated with renal cell carcinoma.
    Rosenblum SL
    J S C Med Assoc; 1987 Jul; 83(7):375-8. PubMed ID: 3475504
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.